United StatesBreaking News

908 Devices (NASDAQ:MASS) reported second-quarter 2026 revenue of $16.1 million, up 23% year over year, as VipIR and NIRLab sales supported growth.

US sales of existing homes fell to a three-month low in July as elevated prices and mortgage rates continued to weigh on the housing market. Michael McKee reports on "Bloomberg Open Interest."

AST SpaceMobile (NASDAQ:ASTS) reported second-quarter 2026 revenue of $31.5 million, driven by gateway deliveries and U.S. government milestones, while net loss reached $230.9 million.

Ceragon (NASDAQ:CRNT) reported second-quarter 2026 revenue of $93.9 million, up 14.2% from $82.3 million a year earlier.

Eli Lilly (NYSE:LLY) received U.K. approval for Foundayo on August 10 for adult weight management and insufficiently controlled type 2 diabetes.

DPC Holdings (NYSE:DPC) reported second-quarter 2026 revenue of $269 million, up 34% from $201 million a year earlier.

Janus International Group (NYSE:JBI) reported fiscal second-quarter 2026 revenue of $233.5 million, up 2.4%, while net income reached $10.7 million.

ECARX Holdings (NASDAQ:ECX) reported second-quarter 2026 revenue of US$225.2 million, up 45% year over year, while gross margin reached 19.8%.

Hims & Hers Health (NYSE:HIMS) reported second-quarter 2026 revenue of $753.2 million, up 38% from $544.8 million a year earlier.

IHS Holding (NYSE:IHS) reported second-quarter 2026 revenue from continuing operations of $428.6 million, up 10.4% from $388.2 million a year earlier.

Broadwind (NASDAQ:BWEN) reported second-quarter 2026 continuing-operations revenue of $24.3 million, up 67% year over year, while adjusted EBITDA reached $1.6 million.

Laura Cooper, Nuveen Global Investment Strategist, joins Bloomberg's Vonnie Quinn on "Bloomberg Brief" to discuss the rise in real yields and the case for the Federal Reserve's policy tightening.